Publication | Closed Access

Wogonin reverses multi-drug resistance of human myelogenous leukemia K562/A02 cells via downregulation of MRP1 expression by inhibiting Nrf2/ARE signaling pathway

Hematological MalignancyMrp1 ExpressionMalignant Blood DisorderCell DeathCell BiologyMulti-drug ResistanceTumor SuppressorMedicineRadiation OncologyCell SignalingCancer ResearchMyeloid Neoplasia